British Columbia-based AbCellera Biologics has secured a site near its new headquarters under construction in Vancouver where it plans to construct a 130,000-square-foot manufacturing facility to produce new antibody therapies.
British Columbia-based AbCellera Biologics has secured a site near its new headquarters under construction in Vancouver where it plans to construct a 130,000-square-foot manufacturing facility to produce new antibody therapies.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
810 Evans Av, Vancouver, BC